I have a completely different take. I think he took that article by the researcher at the RBL (GMU) who published a paper already posted here on the work regarding peptides working against CV. I read that paper and there was nothing about Brilacidin.
Didn't think there would be - Why?
The researcher who did the lung studies at the RBL is the same person who is going to be writing that peer-reviewed article to be forthcoming soon and also the same person that wants to do an entire PAN-CORONA investigation of Brilacidin against all coronaviruses. Now why would he want to publicize anything about Brilacidin now (outside of the lung tissue test peer review article) prior to doing all the other testing for B across the spectrum of CV? This research should set this guy up for life as far as professional recognition goes as he will be THE MAN who spotlighted and delved into the entire possibilities of B working against CV and other viruses. He is not going to blow that now by letting other researchers in on his golden egg.
It is excellent that Dr. Marakay is aware of the powers of peptides and those who just emailed him about B should have a better chance of him reading the information since it is an AMP.
News 
Market Data 
Discover 
AI
